Lancaster Cancer Center is a clinical research site located in Lancaster, Pennsylvania, United States 17605.
Crixeo Clinical Trials Trust Score: 18/100 (FAILING). This profile has not yet been claimed by the site owner.
Lancaster Cancer Center has participated in 12 clinical trials.
Therapeutic areas: Multiple Myeloma, Relapsed or Refractory Multiple Myeloma, Lung Cancer.
Sponsors: Celgene, Novartis Pharmaceuticals, Fox Chase Cancer Center.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Lancaster
Trust Score: 18/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Lancaster Cancer Center has a Crixeo Trust Score of 18/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lancaster Cancer Center has 12 clinical trials on record. Their work covers Multiple Myeloma, Relapsed or Refractory Multiple Myeloma, Lung Cancer.
Lancaster Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.